Abstract
BACKGROUND: There is wide variation in the phenotypic expression of Parkinson's disease (PD), which is driven by both genetic and epidemiological influences.
OBJECTIVES: To define and explain variation in the clinical phenotype of PD, in relation to genotypic variation.
METHODS: Tracking Parkinson's is a multicentre prospective longitudinal epidemiologic and biomarker study of PD. Patients attending specialist clinics in the United Kingdom with recent onset (<3.5 years) and young onset (diagnosed <50 years of age) PD were enrolled. Motor, non-motor and quality of life assessments were performed using validated scales. Cases are followed up 6 monthly up to 4.5 years for recent onset PD, and up to 1 year for young onset PD. We present here baseline clinical data from this large and demographically representative cohort.
RESULTS: 2247 PD cases were recruited (1987 recent onset, 260 young onset). Recent onset cases had a mean (standard deviation, SD) age of 67.6 years (9.3) at study entry, 65.7% males, with disease duration 1.3 years (0.9), MDS-UPDRS 3 scores 22.9 (12.3), LEDD 295 mg/day (211) and PDQ-8 score 5.9 (4.8). Young onset cases were 53.5 years old (7.8) at study entry, 66.9% male, with disease duration 10.2 years (6.7), MDS-UPDRS 3 scores 27.4 (15.3), LEDD 926 mg/day (567) and PDQ-8 score 11.6 (6.1).
CONCLUSIONS: We have established a large clinical PD cohort, consisting of young onset and recent onset cases, which is designed to evaluate variation in clinical expression, in relation to genetic influences, and which offers a platform for future imaging and biomarker research.
Original language | English |
---|---|
Pages (from-to) | 947-959 |
Number of pages | 13 |
Journal | Journal of Parkinson's Disease |
Volume | 5 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- Adult
- Age of Onset
- Aged
- Female
- Follow-Up Studies
- Genotype
- Humans
- Male
- Middle Aged
- Parkinson Disease
- Phenotype
- Research Design
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't